About: Psychoactive Substances Act 2013     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WrittenCommunication106349220, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FPsychoactive_Substances_Act_2013

The Psychoactive Substances Act 2013 is a law in New Zealand. The purpose of the Act is to regulate the availability of psychoactive substances in New Zealand to protect the health of, and minimise harm to, individuals who use psychoactive substances. The law seeks to make manufacturers test and prove their products are low-risk before they can be sold.

AttributesValues
rdf:type
rdfs:label
  • Psychoactive Substances Act 2013 (en)
rdfs:comment
  • The Psychoactive Substances Act 2013 is a law in New Zealand. The purpose of the Act is to regulate the availability of psychoactive substances in New Zealand to protect the health of, and minimise harm to, individuals who use psychoactive substances. The law seeks to make manufacturers test and prove their products are low-risk before they can be sold. (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Coat_of_arms_of_New_Zealand.svg
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
thumbnail
imagesize
introduced by
legislature
short title
  • Psychoactive Substances Act (en)
status
  • Current (en)
1st reading
date commenced
has abstract
  • The Psychoactive Substances Act 2013 is a law in New Zealand. The purpose of the Act is to regulate the availability of psychoactive substances in New Zealand to protect the health of, and minimise harm to, individuals who use psychoactive substances. The law seeks to make manufacturers test and prove their products are low-risk before they can be sold. Testing is expected to cost manufacturers $1 to 2 million dollars. There is also an $180,000 application fee. A later addition to the law, Section 4(f), specified that "animals must not be used in trials for the purposes of assessing whether a psychoactive product should be approved." This may mean that, in practice, approval will be difficult or impossible. So far, no manufacturing licenses have been applied for. The Act was brought in as a reaction to widespread concerns over the 2005 deregulation, or decriminalisation, of selling psychoactive substances in New Zealand with the introduction of section 62 in the Misuse of Drugs Amendment Act 2005 and the Misuse of Drugs (Restricted Substances) Regulations 2008.These laws made psychoactive substances such as party pills and legal highs available in New Zealand in a relatively new experimental market aimed at decriminalising the production and sale of recreational drugs. (en)
bill citation
royal assent
gold:hypernym
prov:wasDerivedFrom
page length (characters) of wiki page
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is Wikipage redirect of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 59 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software